Ottawa Heart Institute Research Corporation: Atrial Fibrillation trials

The registry lists 22 Atrial Fibrillation studies with Ottawa Heart Institute Research Corporation as lead sponsor. 6 are open to participants now and 2 have results posted.

Phase 3 2Phase 4 1No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)RecruitingNCT07002450Not applicable
• MAX - SHOCK Clinical TrialRecruitingNCT06556667Not applicable
• QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)RecruitingNCT05136131Not applicable
• Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein IsolationRecruitingNCT04823299Not applicable
• Exercise Training in Patients With Persistent or Permanent Atrial FibrillationRecruitingNCT03397602Not applicable
• Predicting Development of SCAF in Device PatientsRecruitingNCT02808260
• Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out ThrombusCompletedNCT04223505Not applicableResults posted
• Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial FibrillationCompletedNCT01420393Not applicableResults posted
• Acute Responses to Exercise in Females and Males With Symptomatic Atrial FibrillationCompletedNCT05085860Not applicable
• The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation SymptomsCompletedNCT04190212Not applicable
• Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKsTerminatedNCT03467633Not applicable
• Characterization of Arrhythmia Substrate to Ablate Persistent Atrial FibrillationActive, not recruitingNCT03347227Not applicable
• The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary InterventionCompletedNCT03331484Phase 3
• Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise TrainingCompletedNCT02627183
• Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)Active, not recruitingNCT02602457Not applicable
• Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation StudyActive, not recruitingNCT02184013Not applicable
• Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation TrialCompletedNCT02168829Phase 4
• Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation RecurrenceActive, not recruitingNCT02150902Not applicable
• A Study of Caffeine on Cardiac ArrhythmiasCompletedNCT02095405Not applicable
• Autonomic Innervation and MIBG ImagingCompletedNCT02071680Phase 3
• Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial FibrillationCompletedNCT01994252Not applicable
• Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial FibrillationCompletedNCT00745706Not applicable